Mariner Investment Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Mariner Investment Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-169,000	Closed	-$1.25M	–	143
2016 Q2	$1.25M	Buy	169,000 +26,200	+18%	+$197K	0.42%	65
2016 Q1	$912K	Hold	142,800	–	–	0.25%	99
2015 Q4	$893K	Hold	142,800	–	–	0.2%	121
2015 Q3	$834K	Hold	142,800	–	–	0.17%	130
2015 Q2	$1.18M	Sell	142,800 -47,500	-25%	-$420K	0.3%	103
2015 Q1	$1.57M	Sell	190,300 -100,000	-34%	-$739K	0.42%	79
2014 Q4	$1.99M	Sell	290,300 -50,000	-15%	-$313K	0.34%	80
2014 Q3	$1.84M	Buy	340,300 +700	+0.2%	+$4.09K	0.38%	66
2014 Q2	$2.16M	Buy	339,600 +255,000	+301%	+$1.75M	0.42%	61
2014 Q1	$682K	Buy	+84,600	New	+$659K	0.15%	105

Other funds holding ARIA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Mariner Investment Group's ARIA Position: Q3 2016 in Review

Mariner Investment Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 169,000 shares — an estimated $1.25M sold.

Mariner Investment Group first reported a position in ARIA in Q1 2014 and held it in 10 quarters. The position peaked at $2.16M in Q2 2014. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

Mariner Investment Group reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 169,000 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $1.25M.
Mariner Investment Group first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 10 quarters.
Mariner Investment Group's Ariad Pharmaceuticals Inc position peaked at $2.16M in Q2 2014.
202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.